Clinical Trials Browser

Recruiting × Maintenance × 90 days × Clear all

NCT06656598 2026-02-11

SPORADIC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07372365 2026-01-28

Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.

Phase 2 Recruiting

Lymphoma, B-Cell, Marginal Zone